AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15044399 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 139
Study 16108864 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 42
Study 16108864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 10614810 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced transthoracic echocardiography
Number of subjects: 0
Study 10614810 — intervention group
Group type: COMPARATOR
Intervention: Cine magnetic resonance imaging
Number of subjects: 0
Study 9005613 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant trimetazidine (Preductal)
Number of subjects: 86
Study 9005613 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (thrombolytic drugs, beta‐blockers, APP inhibitors, nitrates, aspirin)
Number of subjects: 86
Study 1883434 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal statements from fictitious residency candidates (three men, three women)
Number of subjects: 6064
Study 6979982 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 10 mg every 6 hours enterally starting the morning after surgery (Group I, 50 patients)
Number of subjects: 100
Study 6979982 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II, 50 patients)
Number of subjects: 100
Study 30888251 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoelectric computer interface (MyoCI) training (60 vs 90 minutes)
Number of subjects: 32
Study 30888251 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoelectric computer interface (MyoCI) training without arm restraint (90 minutes)
Number of subjects: 32
Study 30888251 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoelectric computer interface (MyoCI) training (90 minutes)
Number of subjects: 32
Study 30888251 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoelectric computer interface (MyoCI) training
Number of subjects: 32
Study 30120033 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT) program for sensori‐motor impairment
Number of subjects: 31
Study 30120033 — intervention group
Group type: COMPARATOR
Intervention: Conventional program (control)
Number of subjects: 31
Study 26847983 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic limb movements (PLMs)
Number of subjects: 89
Study 26847983 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (BP) elevations with PLMs
Number of subjects: 89
Study 26847983 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure (BP) elevations with PLMs
Number of subjects: 89
Study 25533442 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 287
Study 25533442 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 287
Study 22311960 — intervention group
Group type: EXPERIMENTAL
Intervention: MiQuit (tailored self-help leaflet and 11-week tailored text messages)
Number of subjects: 207
Study 22311960 — intervention group
Group type: COMPARATOR
Intervention: Control (nontailored self-help leaflet)
Number of subjects: 207
Study 18502028 — intervention group
Group type: EXPERIMENTAL
Intervention: Propiverine (10 or 15 mg twice daily)
Number of subjects: 171
Study 18502028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 17944740 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg b.d. + Placebo
Number of subjects: 14
Study 17944740 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d. + Ranitidine 300 mg at bedtime
Number of subjects: 14
Study 15854087 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg oral prednisolone once daily perioperatively (Group I, n = 20)
Number of subjects: 40
Study 15854087 — intervention group
Group type: COMPARATOR
Intervention: Identical placebo (Group II, n = 20)
Number of subjects: 40
Study 12408530 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction group (IFN 3 MU daily for 14 days, then 3 MU three times a week)
Number of subjects: 31
Study 12408530 — intervention group
Group type: COMPARATOR
Intervention: Standard group (IFN 3 MU three times a week from start)
Number of subjects: 31
Study 10225553 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (treatment duration up to 48 days)
Number of subjects: 366
Study 10225553 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (treatment duration 49 or more days)
Number of subjects: 366
Study 7869940 — intervention group
Group type: EXPERIMENTAL
Intervention: dF 30 mg acutely (n = 6)
Number of subjects: 11
Study 7869940 — intervention group
Group type: EXPERIMENTAL
Intervention: dF 15 mg twice daily for 15 days (chronic)
Number of subjects: 11
Study 7869940 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 5)
Number of subjects: 11
Study 31394154 — intervention group
Group type: EXPERIMENTAL
Intervention: Rewarming duration (time from 34°C to 36°C)
Number of subjects: 328
Study 31607604 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral poliovirus vaccine (OPV) co-administered with RV3-BB
Number of subjects: 1649
Study 31607604 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated polio vaccine (IPV) co-administered with RV3-BB
Number of subjects: 1649
Study 31607604 — intervention group
Group type: COMPARATOR
Intervention: Oral poliovirus vaccine (OPV)
Number of subjects: 1649
Study 27381488 — intervention group
Group type: COMPARATOR
Intervention: Lecture only (30-min lecture)
Number of subjects: 87
Study 27381488 — intervention group
Group type: COMPARATOR
Intervention: Lecture and App (30-min lecture + access to Dental Trauma App)
Number of subjects: 87
Study 27381488 — intervention group
Group type: EXPERIMENTAL
Intervention: App only (access to Dental Trauma App)
Number of subjects: 87
Study 26242222 — intervention group
Group type: EXPERIMENTAL
Intervention: Test capecitabine tablets (T)
Number of subjects: 46
Study 26242222 — intervention group
Group type: COMPARATOR
Intervention: Reference capecitabine tablets (R)
Number of subjects: 46
Study 26242222 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR C677T genotype
Number of subjects: 46
Study 24041978 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (E+P) therapy
Number of subjects: 16608
Study 24041978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16608
Study 21747300 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG)
Number of subjects: 30
Study 21747300 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training Group (ETG)
Number of subjects: 30
Study 21747300 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study 17623819 — intervention group
Group type: EXPERIMENTAL
Intervention: Glargine
Number of subjects: 24
Study 17623819 — intervention group
Group type: EXPERIMENTAL
Intervention: Detemir
Number of subjects: 24
Study 16217004 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional liability insurance market changes
Number of subjects: 727
Study 16217004 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination of specific services
Number of subjects: 727
Study 16217004 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical specialists and general surgeons
Number of subjects: 727
Study 16217004 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstetrician/gynecologists and family medicine physicians
Number of subjects: 727
Study 16217004 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in professional liability insurance premiums
Number of subjects: 727
Study 12110490 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual screening (invited to three further annual screens)
Number of subjects: 99389
Study 12110490 — intervention group
Group type: COMPARATOR
Intervention: 3-yearly screening (invited to the standard single screen 3 years later)
Number of subjects: 99389
Study 10366230 — intervention group
Group type: COMPARATOR
Intervention: Generalized chronic inflammatory demyelinating polyneuropathy (G-CIDP)
Number of subjects: 10
Study 10366230 — intervention group
Group type: COMPARATOR
Intervention: Multifocal motor neuropathy (MMN)
Number of subjects: 10
Study 10366230 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb predominant CIDP (UL-CIDP)
Number of subjects: 10
Study 7717597 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment with antimicrobial therapy for 7 days
Number of subjects: 191
Study 7717597 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (control group)
Number of subjects: 191
Study 7717597 — intervention group
Group type: COMPARATOR
Intervention: Non-bacteriuric group
Number of subjects: 191
Study 2392131 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim-sulfamethoxazole (20 and 100 mg per kilogram of body weight per day)
Number of subjects: 60
Study 2392131 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim-dapsone (20 mg per kilogram per day and 100 mg per day)
Number of subjects: 60
Study 7174862 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 46
Study 7174862 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 46
Study 31156265 — intervention group
Group type: EXPERIMENTAL
Intervention: Karo Light syrup
Number of subjects: 24
Study 31156265 — intervention group
Group type: COMPARATOR
Intervention: Crown Lily White syrup
Number of subjects: 24
Study 29040837 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape intake (5 g/kg body weight/day for 3 weeks)
Number of subjects: 30
Study 29040837 — intervention group
Group type: COMPARATOR
Intervention: Control group (no grape intake)
Number of subjects: 30
Study 26611434 — intervention group
Group type: EXPERIMENTAL
Intervention: 100mg enteric-coated aspirin
Number of subjects: 1262
Study 26611434 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 1262
Study 23440491 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of antenatal depressive symptoms (K-10 score >6)
Number of subjects: 365
Study 23440491 — intervention group
Group type: EXPERIMENTAL
Intervention: Vomiting
Number of subjects: 365
Study 23440491 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemia
Number of subjects: 365
Study 23440491 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient intakes, serum vitamin B12, methylmalonic acid, homocysteine, and red cell folate levels
Number of subjects: 365
Study 23160103 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A received the debriefing information in the body of an email with links to protocol and results pages.
Number of subjects: 11943
Study 23160103 — intervention group
Group type: COMPARATOR
Intervention: Group B was presented with links after clicking on an initial link in the body of the email to view the debriefing information on a website.
Number of subjects: 11943
Study 19390079 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy during coiling
Number of subjects: 1422
Study 19390079 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy after coiling
Number of subjects: 1422
Study 19390079 — intervention group
Group type: COMPARATOR
Intervention: No antiplatelet therapy during coiling
Number of subjects: 1422
Study 19390079 — intervention group
Group type: COMPARATOR
Intervention: No antiplatelet therapy after coiling
Number of subjects: 1422
Study 17272770 — intervention group
Group type: EXPERIMENTAL
Intervention: Above median hsCRP level (> or =0.21 mg/L)
Number of subjects: 514
Study 17272770 — intervention group
Group type: EXPERIMENTAL
Intervention: Silent cerebral infarcts (SCIs)
Number of subjects: 514
Study 17272770 — intervention group
Group type: EXPERIMENTAL
Intervention: Above median hsCRP level and SCIs at baseline
Number of subjects: 514
Study 17272770 — intervention group
Group type: EXPERIMENTAL
Intervention: Below median hsCRP level and SCIs
Number of subjects: 514
Study 17272770 — intervention group
Group type: EXPERIMENTAL
Intervention: Above median hsCRP level without SCIs
Number of subjects: 514
Study 16276447 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL 2% lidocaine and 0.5 mL betamethasone (7 mg/mL)
Number of subjects: 17
Study 16276447 — intervention group
Group type: COMPARATOR
Intervention: 1 mL 1% lidocaine and 0.5 mL betamethasone (7 mg/mL)
Number of subjects: 17
Study 12105256 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab (SIM group) with dual maintenance immunosuppression (prednisolone and cyclosporin A)
Number of subjects: 42
Study 12105256 — intervention group
Group type: COMPARATOR
Intervention: Antilymphocyte globulin (ALG group) with triple maintenance immunosuppression (prednisolone, cyclosporin A, and azathioprine)
Number of subjects: 42
Study 12105256 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab (SIM group)
Number of subjects: 42
Study 12105256 — intervention group
Group type: COMPARATOR
Intervention: Antilymphocyte globulin (ALG group)
Number of subjects: 42
Study 10206565 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 309
Study 10206565 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 309
Study 10206565 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall interference of pain and emotional upset due to pain
Number of subjects: 309
Study 10206565 — intervention group
Group type: EXPERIMENTAL
Intervention: Threat appraisal
Number of subjects: 309
Study 10206565 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenge appraisal
Number of subjects: 309
Study 10206565 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care utilization
Number of subjects: 309
Study 7792377 — intervention group
Group type: EXPERIMENTAL
Intervention: Social affiliation (accompanied by a close friend) under high social threat
Number of subjects: 96
Study 7792377 — intervention group
Group type: COMPARATOR
Intervention: Social affiliation (alone) under high social threat
Number of subjects: 96
Study 7792377 — intervention group
Group type: COMPARATOR
Intervention: Social affiliation (accompanied by a close friend) under low social threat
Number of subjects: 96
Study 7792377 — intervention group
Group type: COMPARATOR
Intervention: Social affiliation (alone) under low social threat
Number of subjects: 96
Study 7792377 — intervention group
Group type: EXPERIMENTAL
Intervention: Social affiliation (both conditions)
Number of subjects: 96
Study 2222942 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine oil (n = 8)
Number of subjects: 16
Study 2222942 — intervention group
Group type: COMPARATOR
Intervention: Vegetable oil (n = 8)
Number of subjects: 16
Study 693755 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback training procedure
Number of subjects: 24
Study 693755 — intervention group
Group type: COMPARATOR
Intervention: No feedback training procedure
Number of subjects: 24
Study 693755 — intervention group
Group type: EXPERIMENTAL
Intervention: Both feedback and no feedback training procedures
Number of subjects: 24
Study 31436162 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based independent intervention
Number of subjects: 225
Study 31436162 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face with nurse consultations
Number of subjects: 225
Study 31436162 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based with virtual nurse consultations
Number of subjects: 225
Study 31436162 — intervention group
Group type: COMPARATOR
Intervention: Control group (Web-based independent)
Number of subjects: 225
Study 28850255 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic CT imaging of the scapholunate joint
Number of subjects: 15
Study 26938637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo Biloba (120 mg, 240 mg)
Number of subjects: 24
Study 26938637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng (500 mg, 1000 mg)
Number of subjects: 24
Study 24005256 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured complex intervention based on the Theory of Planned Behaviour (TPB) including practice-based education, skill development, and practical resources
Number of subjects: 160
Study 24005256 — intervention group
Group type: COMPARATOR
Intervention: Control group practices
Number of subjects: 160
Study 23176985 — intervention group
Group type: EXPERIMENTAL
Intervention: G1: hyperbaric bupivacaine (8 mg), sufentanil (2.5 μg), morphine (100 μg)
Number of subjects: 443
Study 23176985 — intervention group
Group type: EXPERIMENTAL
Intervention: G2: hyperbaric bupivacaine (10 mg), sufentanil (2.5 μg), morphine (100 μg)
Number of subjects: 443
Study 23176985 — intervention group
Group type: EXPERIMENTAL
Intervention: G3: hyperbaric bupivacaine (12.5 mg), morphine (100 μg)
Number of subjects: 443
Study 23176985 — intervention group
Group type: EXPERIMENTAL
Intervention: G4: hyperbaric bupivacaine (15 mg), morphine (100 μg)
Number of subjects: 443
Study 23176985 — intervention group
Group type: EXPERIMENTAL
Intervention: G5: hyperbaric bupivacaine (12.5 mg), morphine (100 μg), without perioperative anti‐inflammatory
Number of subjects: 443
Study 21085907 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (900 IU/day P.O. for 6 months)
Number of subjects: 57
Study 21085907 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (walking exercise 3 sessions per week for 6 months)
Number of subjects: 57
Study 21085907 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control (no intervention)
Number of subjects: 57
Study 21085907 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E under training (900 IU/day P.O. for 6 months with exercise)
Number of subjects: 57
Study 17406822 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus interferon and ribavirin
Number of subjects: 0
Study 17406822 — intervention group
Group type: COMPARATOR
Intervention: Pegylated interferon and ribavirin
Number of subjects: 0
Study 16051242 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 microg of misoprostol intravaginally
Number of subjects: 94
Study 16051242 — intervention group
Group type: COMPARATOR
Intervention: Surgical curettage
Number of subjects: 94
Study 16051242 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management (misoprostol)
Number of subjects: 94
Study 12145066 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 60
Study 12145066 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation
Number of subjects: 60
Study 12145066 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of isoflurane and propofol
Number of subjects: 60
Study 10995145 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA (eutectic mixture of local anaesthetic)
Number of subjects: 20
Study 10995145 — intervention group
Group type: EXPERIMENTAL
Intervention: Amethocaine
Number of subjects: 20
Study 7480619 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention with retailers (three educational visits over a 1-year period)
Number of subjects: 236
Study 7480619 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 236
Study 7480619 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention with retailers
Number of subjects: 236
Study 2269834 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic band mobilisation with conventional forearm attachment
Number of subjects: 0
Study 2269834 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic band mobilisation with attachments around the dorsum of the hand or under a palmar pulley
Number of subjects: 0
Study 7308277 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once/day
Number of subjects: 5
Study 7308277 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg twice/day
Number of subjects: 5
Study 7308277 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 300 mg once/day
Number of subjects: 5
Study 7308277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 31999296 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Dose Chemotherapy (HDCT)
Number of subjects: 885
Study 31999296 — intervention group
Group type: COMPARATOR
Intervention: Conventional-Dose Chemotherapy (CDCT)
Number of subjects: 885
Study 30946602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery training combined with electromyogram-triggered neuromuscular electrical stimulation
Number of subjects: 68
Study 30946602 — intervention group
Group type: COMPARATOR
Intervention: Electromyogram-triggered neuromuscular electrical stimulation
Number of subjects: 68
Study 28873050 — intervention group
Group type: EXPERIMENTAL
Intervention: Video animation discharge instruction (6-minute video on proper usage of opioids)
Number of subjects: 52
Study 28873050 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (verbal instruction and informational sheet)
Number of subjects: 52
Study 28873050 — intervention group
Group type: EXPERIMENTAL
Intervention: Video animation discharge instruction
Number of subjects: 52
Study 28873050 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 52
Study 28873050 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of video discharge instruction
Number of subjects: 52
Study 26777124 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy (AF) - 1.1+2.0 Gy/day, 5 days/week in 35 days, total dose 68 Gy
Number of subjects: 750
Study 26777124 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (CF) - 2 Gy/day, 5 days/week in 49 days, total dose 68 Gy
Number of subjects: 750
Study 24421638 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care telephone intervention (first meeting with health professionals and five additional self-care telephone calls)
Number of subjects: 30
Study 24421638 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention or attention, only questionnaires)
Number of subjects: 30
Study 23342612 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg
Number of subjects: 24
Study 23342612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 20518928 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonicare CanalBrush irrigation with 17% EDTA for 1 min, extended by 30 s with sonic agitation (group V)
Number of subjects: 50
Study 20518928 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA irrigation (group III and IV)
Number of subjects: 50
Study 20518928 — intervention group
Group type: COMPARATOR
Intervention: Control group I: 2 mL of distilled water
Number of subjects: 50
Study 20518928 — intervention group
Group type: COMPARATOR
Intervention: Control group II: 2.5% NaOCl
Number of subjects: 50
Study 18507596 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated humidity strategy
Number of subjects: 136